{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:51:32Z","timestamp":1786978292299,"version":"build-2736575974"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is the most common autoimmune encephalitis, primarily affecting the central nervous system (CNS) and typically presenting with neuropsychiatric symptoms. However, emerging evidence suggests that peripheral nervous system (PNS) involvement may also occur in some cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To investigate the clinical and neuro-electrophysiological characteristics of PNS involvement in patients with positive anti-NMDAR antibodies in cerebrospinal fluid (CSF).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively reviewed all patients with CSF-confirmed anti-NMDAR encephalitis at the Second Affiliated Hospital of Guangzhou Medical University between 2016 and 2025. Collected data included initial symptoms and disease severity, CSF and serum test results, magnetic resonance imaging (MRI) and neuro-electrophysiological findings, primary treatment regimens, presence of coexisting autoimmune disorders, and clinical outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 46 patients with anti-NMDAR encephalitis, 9 patients (19.6%) exhibited PNS involvement. The average age of onset in this subgroup with PNS involvement were significantly older than those with CNS involvement only (mean \u00b1 SD: 36.2 \u00b1 18.9 years vs. 24.6 \u00b1 12.4 years;\n                      <jats:italic>P<\/jats:italic>\n                      =\u00a00.029). Limb weakness was significantly more frequent in the PNS involvement group (55.6% vs. 2.7%;\n                      <jats:italic>P<\/jats:italic>\n                      &amp;lt;\u00a00.001). Electromyography (EMG) was performed in 18 patients (39.1%), of whom 10 patients (55.6%) showed abnormal findings. Among these, 1 patient exhibited active radiculopathy associated with motor neuron disease, 2 patients had isolated radiculopathy, and 1 patient presented with mixed polyneuropathy involving both motor and sensory functions. Cranial nerve involvement was observed in 2 patients (22.2%). In one case, PNS involvement was the initial symptom.\n                    <\/jats:p>\n                    <jats:p>All patients received first-line immunotherapy. PNS involvement was not significantly associated with disease prognosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PNS involvement in anti-NMDAR encephalitis is not uncommon and most frequently manifests as acute or subacute limb weakness. Neuro- electrophysiological abnormalities predominantly involve motor conduction pathways and proximal nerve roots. This is a single-center retrospective study with a small sample size. Large-sample prospective studies are needed to further validate the findings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1865306","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T05:55:03Z","timestamp":1786514103000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Peripheral nervous system involvement accompanies central nervous system involvement in anti-N-methyl-D-aspartate receptor encephalitis"],"prefix":"10.3389","volume":"17","author":[{"given":"Wenjie","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Zhu","sequence":"additional","affiliation":[{"name":"Neurology Center, Guangzhou Fosun Chancheng Hospital of Guangdong Pharmaceutical University","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiting","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liran","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youming","family":"Long","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianliang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Institute of Neuroscience, Key Laboratory of Neurogenetics and Channelopathies of Guangdong Province and the Ministry of Education of China","place":["Guangzhou, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000001052","article-title":"International consensus recommendations for the treatment of pediatric NMDAR antibody encephalitis","volume":"8","author":"Nosadini","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/cjn.2024.16","article-title":"Canadian consensus guidelines for the diagnosis and treatment of autoimmune encephalitis in adults","author":"Hahn","year":"2024","journal-title":"Can J Neurol Sci"},{"key":"B3","doi-asserted-by":"publisher","first-page":"284","DOI":"10.21037\/atm-20-2279","article-title":"Autoantibodies detection in anti-N-methyl-D-aspartate receptor encephalitis","volume":"11","author":"Li","year":"2023","journal-title":"Ann Transl Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3785\/j.issn.1008-9292.2020.02.13","article-title":"Research progress on electroencephalogram characteristics of anti-N-methyl-D-aspartate receptor encephalitis","volume":"49","author":"Liu","year":"2020","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2024.09.001","article-title":"Autoimmune encephalitis","volume":"109","author":"Guasp","year":"2025","journal-title":"Med Clin North Am"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fnhum.2023.1261638","article-title":"Systematic review: clinical characteristics of anti-N-methyl-D-aspartate receptor encephalitis","volume":"17","author":"Zhao","year":"2023","journal-title":"Front Hum Neurosci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.genhosppsych.2014.02.010","article-title":"Management of psychiatric symptoms in anti-NMDAR encephalitis: a case series, literature review and future directions","volume":"36","author":"Kuppuswamy","year":"2014","journal-title":"Gen Hosp Psychiatry"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.0000000000210109","article-title":"Functional, and patient-reported outcomes in patients with anti-NMDAR encephalitis","volume":"103","author":"Brenner","year":"2024","journal-title":"Neurology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adn3259","article-title":"Cerebrospinal fluid flow extends to peripheral nerves further unifying the nervous system","volume":"10","author":"Ligocki","year":"2024","journal-title":"Sci Adv"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031529","article-title":"Testing the role of glutamate NMDA receptors in peripheral trigeminal nociception implicated in Migraine Pain","volume":"23","author":"Guerrero-Toro","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.14423","article-title":"N-Methyl-d-aspartate receptor open-channel blockers memantine and magnesium modulate nociceptive trigeminovascular neurotransmission in rats","volume":"50","author":"Hoffmann","year":"2019","journal-title":"Eur J Neurosci"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/mus.25078","article-title":"Functional ionotropic glutamate receptors on peripheral axons and myelin","volume":"54","author":"Christensen","year":"2016","journal-title":"Muscle Nerve"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nature04474","article-title":"NMDA receptors mediate calcium accumulation in myelin during chemical ischaemia","volume":"439","author":"Micu","year":"2006","journal-title":"Nature"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.266047","article-title":"Glutamate receptors and glutamatergic signalling in the peripheral nerves","volume":"15","author":"Chen","year":"2020","journal-title":"Neural Regener Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181fc2a06","article-title":"Retrospective analysis of NMDA receptor antibodies in encephalitis of unknown origin","volume":"75","author":"Pr\u00fcss","year":"2010","journal-title":"Neurology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000042436","article-title":"An adolescent patient with anti-N-methyl-D-aspartate receptor encephalitis with motor aphasia as the first symptom and complicated by peripheral nerve damage: A case report and literature review","volume":"104","author":"Shen","year":"2025","journal-title":"Med (Baltimore)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.52.1065","article-title":"Ophthalmoplegia and flaccid paraplegia in a patient with anti-NMDA receptor encephalitis: a case report and literature review","volume":"52","author":"Ishikawa","year":"2013","journal-title":"Intern Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.5692\/clinicalneurol.50.467","article-title":"A case of anti-Hu antibody- and anti-GluR epsilon2 antibody-positive paraneoplastic neurological syndrome presenting with limbic encephalitis and peripheral neuropathy","volume":"50","author":"Samejima","year":"2010","journal-title":"Rinsho Shinkeigaku"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000000014","article-title":"A case of inflammatory peripheral nerve destruction antedating anti-NMDA receptor encephalitis","volume":"1","author":"Pr\u00fcss","year":"2014","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1159\/000323751","article-title":"A young man with anti-NMDAR encephalitis following Guillain-Barr\u00e9 Syndrome","volume":"3","author":"Tojo","year":"2011","journal-title":"Case Rep Neurol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.779","article-title":"Peripheral neuropathy in limbic encephalitis with anti-glutamate receptor antibodies: Case report and systematic literature review","volume":"7","author":"Wei","year":"2017","journal-title":"Brain Behav"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn101721-20230108-000010","article-title":"A case report of anti-NMDAR encephalitis complicated with acute peripheral nerve damage","volume":"39","author":"Yang","year":"2023","journal-title":"Chin J Gen Pract"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cmcr.2020.e00039","article-title":"A case of anti-NMDAR encephalitis overlapping acute axonal peripheral neuropathy","volume":"2","author":"Shen","year":"2020","journal-title":"Chin Clin Case Repository"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn113694-20220219-00118","article-title":"Chinese expert consensus on the diagnosis and management of autoimmune encephalitis","volume":"55","year":"2022"},{"key":"B25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02611","article-title":"Epidemiology of antibody-positive autoimmune encephalitis in southwest China: A multicenter study","volume":"10","author":"Gu","year":"2019","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2016.125","article-title":"All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class","volume":"22","author":"Castillo-G\u00f3mez","year":"2017","journal-title":"Mol Psychiatry"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2023.1283511","article-title":"Anti-NMDAR antibodies, the blood-brain barrier, and anti-NMDAR encephalitis","volume":"14","author":"Gong","year":"2023","journal-title":"Front Neurol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-017-0011-3","article-title":"Uncoupling the widespread occurrence of anti-NMDAR1 autoantibodies from neuropsychiatric disease in a novel autoimmune model","volume":"24","author":"Pan","year":"2019","journal-title":"Mol Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318228c136","article-title":"Analysis of complement and plasma cells in the brain of patients with anti-NMDAR encephalitis","volume":"77","author":"Martinez-Hernandez","year":"2011","journal-title":"Neurology"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaa250","article-title":"Autoimmune encephalitis mediated by B-cell response against N-methyl-d-aspartate receptor","volume":"143","author":"Wagnon","year":"2020","journal-title":"Brain"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awac088","article-title":"Cervical lymph nodes and ovarian teratomas as germinal centres in NMDA receptor-antibody encephalitis","volume":"145","author":"Al-Diwani","year":"2022","journal-title":"Brain"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577233","article-title":"GFAP IgG associated inflammatory polyneuropathy","volume":"343","author":"Paul","year":"2020","journal-title":"J Neuroimmunol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000026448","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy mimicking acute disseminated encephalomyelitis: A case report","volume":"100","author":"Li","year":"2021","journal-title":"Med (Baltimore)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1177\/17562864231164806","article-title":"Clinical and electrophysiological characteristics of peripheral neuropathy in autoimmune glial fibrillary acidic protein astrocytopathy: an observational study and literature review","volume":"16","author":"Deng","year":"2023","journal-title":"Ther Adv Neurol Disord"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2019.101924","article-title":"Autoimmune glial fibrillary acidic protein astrocytopathy resulting in treatment-refractory flaccid paralysis","volume":"39","author":"Allen","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.355742","article-title":"Anti-IgLON5 disease: a novel topic beyond neuroimmunology","volume":"18","author":"Zhang","year":"2023","journal-title":"Neural Regener Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.753856","article-title":"Ocular motor abnormalities in anti-IgLON5 disease","volume":"12","author":"Macher","year":"2021","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000000385","article-title":"IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients","volume":"4","author":"Honorat","year":"2017","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1515\/revneuro-2024-0027","article-title":"The role of antibodies in small fiber neuropathy: a review of currently available evidence","volume":"35","author":"Morelli","year":"2024","journal-title":"Rev Neurosci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2020.106187","article-title":"Clinical characteristics of patients double positive for CASPR2 and LGI1-antibodies","volume":"197","author":"Jia","year":"2020","journal-title":"Clin Neurol Neurosurg"},{"key":"B42","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/mus.27188","article-title":"Peripheral nerve hyperexcitability syndrome: A clinical, electrophysiological, and immunological study","volume":"63","author":"Wu","year":"2021","journal-title":"Muscle Nerve"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11908-7","article-title":"Peripheral nervous system involvement accompanies central nervous system involvement in anti-glial fibrillary acidic protein (GFAP) antibody-related disease","volume":"270","author":"Theuriet","year":"2023","journal-title":"J Neurol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003173","article-title":"Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up","volume":"87","author":"van Sonderen","year":"2016","journal-title":"Neurology"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-200110000-00015","article-title":"Critical illness polyneuropathy","volume":"14","author":"Hund","year":"2001","journal-title":"Curr Opin Neurol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/pin.12732","article-title":"Histopathological characterization of the neuroglial tissue in ovarian teratoma associated with anti-N-methyl-D-aspartate (NMDA) receptor encephalitis","volume":"68","author":"Iemura","year":"2018","journal-title":"Pathol Int"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1212\/nxi.0000000000000633","article-title":"Anti-NMDAR encephalitis: A single-center, longitudinal study in China","volume":"7","author":"Xu","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000043338","article-title":"Anti-NMDAR encephalitis triggered by EBV and HSV-1: A case report and literature review","volume":"104","author":"Zhan","year":"2025","journal-title":"Med (Baltimore)"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-020-04785-9","article-title":"HSV encephalitis triggered anti-NMDAR encephalitis: a case report","volume":"42","author":"Hu","year":"2021","journal-title":"Neurol Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02592-07","article-title":"Mechanisms of varicella-zoster virus neuropathogenesis in human dorsal root ganglia","volume":"82","author":"Reichelt","year":"2008","journal-title":"J Virol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-017-0556-y","article-title":"NMDAR encephalitis following herpes simplex virus encephalitis","volume":"19","author":"Galli","year":"2017","journal-title":"Curr Infect Dis Rep"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2012.11.013","article-title":"Role of the N-methyl-d-aspartate receptors complex in amytrophic lateral sclerosis","volume":"1832","author":"Spalloni","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-009-0582-4","article-title":"Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma","volume":"118","author":"T\u00fcz\u00fcn","year":"2009","journal-title":"Acta Neuropathol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1080\/01658107.2021.2014892","article-title":"Recurrent optic neuritis in paediatric anti-N-methyl-D-aspartate receptor (Anti-NMDAR) encephalitis: case report and literature review","volume":"46","author":"Chan","year":"2022","journal-title":"Neuroophthalmology"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30244-3","article-title":"An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models","volume":"18","author":"Dalmau","year":"2019","journal-title":"Lancet Neurol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1212\/con.0000000000000817","article-title":"Physiology and pathophysiology of the autonomic nervous system","volume":"26","author":"Benarroch","year":"2020","journal-title":"Continuum (Minneap Minn)"},{"key":"B57","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.autneu.2015.07.435","article-title":"Autonomic dysfunction in NMDA receptor encephalitis \u2013 Is it central or peripheral in origin","volume":"192","author":"Shah","year":"2015","journal-title":"Autonomic Neuroscience: Basis Clin"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.0167-10.2010","article-title":"Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis","volume":"30","author":"Hughes","year":"2010","journal-title":"J Neurosci"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2022.09.010","article-title":"Post-acute anti-NMDAR encephalitis mirrors schizophrenia","volume":"28","author":"Mu\u00f1iz-Castrillo","year":"2022","journal-title":"Trends Mol Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2020.102604","article-title":"The clinical features and prognosis of anti-NMDAR encephalitis Depends on Blood Brain Barrier Integrity","volume":"47","author":"Yu","year":"2021","journal-title":"Mult Scler Relat Disord"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1865306\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:47:33Z","timestamp":1786974453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1865306\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":60,"alternative-id":["10.3389\/fimmu.2026.1865306"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1865306","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]},"article-number":"1865306"}}